In Table 2 of the original publication, the HGVS and legacy nomenclature were mismatched and the HGVS nomenclature did not correlate with data listed in the table. The corrected table is listed below.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s10549-015-3361-z | DOI Listing |
Publication Analysis
Top Keywords
erratum incidence
4
incidence brca1
4
brca1 brca2
4
brca2 non-founder
4
non-founder mutations
4
mutations patients
4
patients ashkenazi
4
ashkenazi jewish
4
jewish ancestry
4
ancestry table
4
Similar Publications
Publisher Correction: Anti-integrin αvβ6 antibody as a biomarker for diagnosing ulcerative colitis: a nationwide multicenter validation study.
J Gastroenterol
December 2024
Department of Gastroenterology and Hepatology, Graduate School of Medicine, Kyoto University, 54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan.
Correction: Micronutrient intake and telomere length: findings from the UK Biobank.
Eur J Nutr
December 2024
Department of Cardiovascular Sciences, University of Leicester, Leicester, UK.
Corrigendum: CDK4/6 inhibitors improve the anti-tumor efficacy of lenvatinib in hepatocarcinoma cells.
Front Oncol
December 2024
Department of Medicine and Surgery, University of Parma, Parma, Italy.
[This corrects the article DOI: 10.3389/fonc.2022.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!